A dual-luciferase bioluminescence system for the assessment of cellular therapies.

Abstract

Bioluminescence imaging is a well-established platform for evaluating engineered cell therapies in preclinical studies. However, despite the discovery of new luciferases and substrates, optimal combinations to simultaneously monitor two cell populations remain limited. This makes the functional assessment of cellular therapies cumbersome and expensive, especially in preclinical in vivo models. In this study, we explored the potential of using a green bioluminescence-emitting click beetle luciferase, CBG99, and a red bioluminescence-emitting firefly luciferase mutant, Akaluc, together to simultaneously monitor two cell populations. Using various chimeric antigen receptor T cells and tumor pairings, we demonstrate that these luciferases are suitable for real-time tracking of two cell types using 2D and 3D cultures in vitro and experimental models in vivo. Our data show the broad compatibility of this dual-luciferase (duo-luc) system with multiple bioluminescence detection equipment ranging from benchtop spectrophotometers to live animal imaging systems. Although this study focused on investigating complex CAR T cells and tumor cell interactions, this duo-luc system has potential utility for the simultaneous monitoring of any two cellular components-for example, to unravel the impact of a specific genetic variant on clonal dominance in a mixed population of tumor cells.

• Authors: Alejandro G Torres Chavez, Mary K McKenna, Kishore Balasubramanian, Lisa Riffle, Nimit L Patel, Joseph D Kalen, Brad St Croix, Ann M Leen, Pradip Bajgain
• Journal: Molecular therapy. Oncology (Mol Ther Oncol) Vol. 32 Issue 1 Pg. 200763 (Mar 21 2024) ISSN: 2950-3299 [Print] United States
• PMID: 38596291 (Publication Type: Journal Article)
• Copyright: © 2024 The Author(s).